Activation of mTORC2 and thus SGK1-phosphorylated NDRG1 is increased in temozolomide resistant glioma cell lines and NDRG1 expression is elevated in tissues specimens from glioma patients, suggesting that this is mechanistically important for MGMT-conferred resistance to alkylating therapeutics [78]. This evidence concerns the gene SGK1 and glioma.